Oncobone Therapeutics Ltd
13249925
Some Concerns
- No accounts filed in last 18 months (-5)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 16/06/2021
CHIEF SCIENTIFIC OFFICER
FINNISH · FINLAND · Age 39
director · Since 04/05/2024
ANALYST
ITALIAN · ENGLAND · Age 67
Also on 1 other board
Persons with Significant Control
Former PSCs
Dr Satu Vainikka
Ceased 16/06/2021
Mr Tarquin David Fletcher Edwards
Ceased 16/06/2021
CompanyRankvs 1961+ SIC 72110 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2023
Net Worth
£39k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£40k
Working capital
Current Assets
£3k
Current Liabilities
£42k
Fixed Assets
£1k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 0.06 | +£29k |
| 2022 | 0.24 | +£2k |
| 2022 | Infinity | — |
Derived from filed accounts. Not audited figures.